GigaGen, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Subsidiary
- Established
- 2010-03-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.gigagen.com
A Dose Escalation and Expansion Study of GIGA-564 in Participants With Locally Advanced or Metastatic Solid Tumor Malignancies
Phase 1
Recruiting
- Conditions
- Advanced or Metastatic Solid Tumor Malignancies
- Interventions
- First Posted Date
- 2024-02-14
- Last Posted Date
- 2025-04-10
- Lead Sponsor
- GigaGen, Inc.
- Target Recruit Count
- 60
- Registration Number
- NCT06258304
- Locations
- 🇺🇸
National Cancer Institute, Bethesda, Maryland, United States
Recombinant Hyperimmune Polyclonal Antibody (GIGA-2050) in COVID-19 Patients
- First Posted Date
- 2021-05-12
- Last Posted Date
- 2022-01-26
- Lead Sponsor
- GigaGen, Inc.
- Target Recruit Count
- 3
- Registration Number
- NCT04883138
- Locations
- 🇺🇸
Icahn School of Medicine at Mount Sinai, New York, New York, United States
© Copyright 2025. All Rights Reserved by MedPath